show add
hide add

Methods of treating androgenic alopecia with finasteride


United States Patent     5,571,817

Rasmusson, et al.     Nov. 5, 1996

 

Inventors:

Rasmusson; Gary H. (Watchung, NJ); Reynolds; Glenn F. (Westfield, NJ).

 

Assignee:

Merck & Co., Inc. (Rahway, NJ).

 

Appl. No:

94,815

 

Filed:

Jul. 20, 1993

 

Related U.S. Application Data:

Continuation of (including streamline cont.) Ser. No. 16,476, Feb. 10, 1993, abandoned, which is a continuation of Ser. No. 927,256, Aug. 7, 1992, abandoned, which is a continuation of Ser. No. 698,374, May 9, 1991, abandoned, which is a continuation of Ser. No. 545,676, Jun. 28, 1990, abandoned, which is a continuation of Ser. No. 370,142, Jun. 21, 1989, abandoned, which is a continuation of Ser. No. 198,708, May 19, 1988, abandoned, which is a continuation of Ser. No. 34,806, Apr. 3, 1987, abandoned, which is a continuation-in-part of Ser. No. 800,623, Nov. 21, 1985, Pat. No. 4,760,071, which is a continuation of Ser. No. 584,062, Feb. 27, 1984, abandoned.

Intl. Cl.: A61K 31/44

Current U.S. Cl.: 514/284; 546/77

Field of Search: 546/77; 514/284

 

Abstract:

17.beta.-N-monosubstituted-carbamoyl-4-5.alpha.-androst-1-en-3-ones of the formula ##STR1## wherein R(^1) is selected from hydrogen, methyl and ethyl and R(^2) is a branched chain alkyl of from 3-12 carbons, and R’, R”, R'” are hydrogen or methyl are active as testosterone 5.alpha.-reductase inhibitors and thus are useful topically for treatment of androgenic alopecia.

2 Claims, No Drawings

References Cited:

U.S. Patent Documents

2,227,876     Jan, 1941     Bolt     260/259

3,239,417     Mar, 1966     Tullio et al.     167/65

3,264,301     Aug, 1966     Doorenbos et al.     260/286

3,285,918     Nov, 1966     Doorenbos et al.     260/251

4,139,619     Feb, 1979     Chidsey, III     424/45

4,220,775     Sept., 1980     Rasmusson et al.     546/77

4,317,817     Mar., 1982     Blohm et al.     424/226

4,377,584     Mar., 1983     Rasmusson et al.     424/258

4,396,615     Aug., 1983     Petrow et al.424/242

4,596,812     Jun., 1986     Chidsey, III et al.     514/256

4,689,345     Aug., 1987     Kasha et al.     514/546

4,732,897     Mar., 1988     Cainelli et al.     514/222

4,760,071     Jul., 1988     Rasmusson et al.     514/284

4,845,104     Jul., 1989     Carlin et al.     514/284

4,859,681     Aug., 1989     Rasmusson et al.     514/284

4,882,319     Nov., 1989     Holt et al.     514/119

4,888,336     Dec., 1989     Holt et al.     514/278

4,910,226     Mar., 1990     Holt et al.     514/573

5,021,575     Jun., 1991     King et al.     546/77

5,049,562     Sept., 1991     Rasmusson et al.     514/284

5,061,802     Oct., 1991     Steinberg et al.     546/77

5,075,450     Dec., 1991     Rasmusson et al.     546/285

5,084,574     Jan., 1992     Bhattacharya et al.     546/77

5,091,380     Feb., 1992     Rasmusson et al.     514/169

5,120,729     Jun., 1992     Chabala et al.     514/210

5,120,742     Jun., 1992     Rasmusson et al.     514/284

5,138,063     Aug., 1992     Rasmusson et al.     546/77

5,151,429     Sept., 1992     Rasmusson et al.     514/284

5,151,430     Sept., 1992     Steinberg et al.     514/284

5,162,332     Nov., 1992     Steinberg et al.     514/284

5,175,155     Dec., 1992     Juniewicz et al.     514/176

5,196,411     Mar., 1993     Rasmusson et al.     514/169

Foreign Patent Documents

970692     Jul., 1975     CA

0004949     Oct., 1979     EP

0155096     Sept., 1985     EP

0277002     Aug., 1988    EP

0289327     Nov., 1988     EP

0314199     May, 1989     EP

0343954     Nov., 1989     EP

0375347     Jun., 1990     EP

0375349     Jun., 1990     EP

0375345     Jun., 1990     EP

0375344     Jun., 1990     EP

0463638     Jan., 1992     EP

1465544     Nov., 1965     FR

59-13719     Jan., 1984     JP

60-116657     Jun., 1985     JP

60-126218     Jul., 1988     JP

83/7859     Nov., 1984     ZA

WO85/05272     Dec., 1985     WO

WO85/05270     Dec., 1985     WO

 

Other References

Orentreich, Ann. Plast. Surg. (United States), Jan. 1978, pp. 116-118, “Medical treatment of baldness”.

Questel. Orbit, JAPIO file (abstract), accession No. 84-013719 (1984).

Derwent WPAT file (abstract), accession No. 85-200306/33 (1985).

Questel. Orbit, JAPIO file (abstract), accession No. 85-116657 (1985).

Neri, et al., “A Biological Profile of Nonsteroidal Antiandrogen, SCH 13521”, Endo., vol. 91, No. 2, pp. 427-437 (1972).

Nayfeh, et al., “Metabolism of Progesterone by Rat Testicular Homogenates”, Steroids, vol. 14, pp. 269-283 (1969).

Voigt, et al., Endo., vol. 92, p. 1216.

Doorenbos, et al., “Synthesis and Antimicrobial Properties of 17 Beta-Isopentyloxy . . . “, J. Pharm. Sci., vol. 62, No. 4 pp. 638-640 (1973).

Doorenbos, et al., “4-17 Alpha-Dimethyl-4-Aza-5 Alpha-Androstan-17 Beta-ol-Acetate . . . “, J. Pharm. Sci., vol. 60, No. 8, pp. 1234-1235 (1971).

Doorenbos, et al., “Synthesis and Evaluation of Antimicrobial Properties . . . “, J. Pharm. Sci., vol. 63, No. 4, pp. 620-622 (1974).

Back, et al., “N-Chloroazasteroids: A Novel Class of Reactive Steroid Analogues”, J. Org. Chem., vol. 54, pp. 1904-1910 (1989).

Liang, et al., “Inhibition of 5 Alpha-Reductase, Receptor Binding and Nuclear Uptake of Androgens . . . “, Chem. Abs., vol. 95, No. 13, p. 99, AB #109055j (1981).

Brooks, et al., “Prostatic Effects Induced in Dogs by Chronic or Acute Oral Administration . . . “, The Prostate, vol. 9, pp. 65-75 (1986).

Kadohama, et al., “Retardation of Prostate Tumor Progression in Nobel Rat . . .”, J NCI, vol. 74, No. 2, pp. 475-486 (1985).

Andriole, et al., “The Effect of 4MA, a Potent Inhibitor of 5 Alpha-Reductase . . . “, The Prostate, vol. 10, pp. 189-197 (1987).

Bingham, et al., “The Metabolism of Testosterone By Human Male Scalp Skin”, J. Endocr. (England), vol. 57, pp. 111-121 (1973).

Kedderis, et al., “Studies with Nitrogen-Containing Steroids and Freshly Isolated Rat Hepatocytes”, Tox. Appl. Pharm., vol. 93, pp. 403-412 (1988).

Liang, et al. “Species Differences in Prostatic Steroid 5-Alpha Reductases . . . “, Endocrinology, vol. 117, pp. 571-579 (1985).

Stone, et al., “Estrogen Formation in Human Prostatic Tissue from Patients . . .”, The Prostate, vol. 9, pp. 311-318 (1986).

Brooks, et al., “5 Alpha Reductase Inhibitory and Anti-Androgenic Activities . . . “, Steroids, vol. 47, pp. 1-19 (1986).

Labrie, et al., “Combination Therapy in Prostate Cancer”, Lancet, vol. 2, #8515, pp. 1095-1096 (1986).

Rasmusson, et al., “Azasteroids: Structure-Activity Relationships for Inhibition . . . “, J. Med. Chem., vol. 29, pp. 2298-2315 (1986).

Rasmusson, et al., “Azasteroids as Inhibitors of Rat Prostatic 5-Alpha Reductase”, J. Med. Chem., vol. 27, pp. 1690-1701 (1984).

Rittmaster, et al., “The Effects of N,N-Diethyl-4-Methyl-3-Oxo-4-Aza-5-Alpha Androstane . . . ” J. Clin. Endo. & Metab., vol. 65, pp. 188-193 (1987).

Metcalf, et al., “Potent Inhibition of Human Steroid 5 Alpha-Reductase . . . “, Bioorganic Chem., vol. 17, pp. 372-376 (1986).

Levy, et al., “Inhibition of Rat Liver Steroid 5 Alpha-Reductase by 3-Androstene . . . “, Biochemistry, vol. 29, pp. 2815-2824 (1990).

Holt, et al., “Steroidal A Ring Aryl Carboxylic Acids . . . “, J. Med. Ch vol. 33, pp. 937-942 (1990).

Levy, et al., “Interaction Between Rat Prostatic Steroid 5 Alpha Reductase . . . “, J. Steroid Biochem, vol., 34, pp. 571-575 (1989).

Holt, et al., “Inhibition of Steroid 5 Alpha-Reductase by Unsaturated.”, J. Med. Chem., vol. 33, pp. 943-950 (1990).

Metcalf, et al., “Inhibitors of Steroid 5 Alpha Reductase in Benign . . . “, TIPS, vol. 10, pp. 491-495 (1989).

Murphy, et al., “The Effect of Estradiol on a 25-Hydroxycholecalciferol Binding Protein . . . “, Steroids, vol. 35, pp. 1-7 (1980).

Diani, et al., “Hair Growth Effects of Oral Administration of Finasteride, a Steroid . . . “, J. Clin. Endo. & Metab., vol. 74, pp. 345-350 (1992).

Presti, Jr., et al., “Multicenter, Randomized, Double-Blind, Placebo Controlled Study . . . “, J. Urology.

Gormley, et al., “A Placebo Controlled Study of Finasteride (MK-906) on Stage D Prostate Cancer”, Abst. of talk at Amer. Urol. Assoc. Mtg. in Canada (1991).

Gormley, et al., “Role of 5 Alpha Reductase Inhibitors in Treatment of Advanced Prostatic Carcinoma”, Urol. Clinics of N. Amer., vol. 18, pp. 93-98 (1991).

Gormley, et al., “Effect of Finasteride on Serum PSA Levels in Men w/Prostate Cancer”, 2nd Intnl. (Jan. 18, 1992).

Huggins, et al., “Studies on Prostatic Cancer”, Cancer Research, pp. 293-297 (1941).

Rainwater, et al., “Prostate-Specific Antigen Testing in Untreated & Treated . . . “, Mayo Clinic Proc., vol. 65, pp. 1118-1126 (1990).

Arai, et al., “Prognostic Significance of Prostate Specific Antigen in Endocrine . . . “, J. of Urol., vol. 144, pp. 1415-1419 (1990).

Hudson, et al., “Clinical Use of Prostate Specific Antigen in Patients with Prostate Cancer”, J. of Urol., vol. 142, pp. 1011-1017 (1989).

Brawer, et al., “Prostate-Specific Antigen in Management of Prostatic Carcinoma”, Supp. to Urology, vol. 33, pp. 11-16 (1989).

Stamey, et al., “Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma . . . “, N. E. Jour. Med., vol. 317, pp. 909-916 (1987).

Walsh, et al., “The Value of Prostate-Specific Antigen in the Management . . . “, Ther. Prog. Urol. Can., pp. 27-33 (1989).

Stamey, et al., “Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma . . . “, J. of Urology, vol. 141, pp. 1070-1075 (1989).

Lange, et al., “The Value of Serum Prostate Specific Antigen Determinations . . . “, J. of Urol., vol. 141, pp. 873-879 (1989).

Hoehn, et al., “Human Prostatic Adenocarcinoma”, The Prostate I, pp. 95-104 (1980).

Helliker, “Alopecia Sufferers Seek to Suffer Less . . . “, Wall Street Journal pp. A1-A7 (1991).

Chemical Engineering News, pp. 7-8 (29 Jun. 1992).

Allen & Hanburys Limited (Hayes’) Appl (1977) RPC 113.

Television Transcript, News 4 New York Live at Five, WNBC-TV, NY, S. Simmons and M. Gomez (Nov. 29, 1993).
Primary Examiner: O’Sullivan; Peter
Attorney, Agent or Firm: Quagliato; Carol S., Winokur; Melvin, North; Robert J.




READ THIS NEXT

    Shampoo for Women

    Blonde girl worried about hair loss

    ProTHIK Spray

    Tagamet (Cimetidine)

    Hair Loss Treatment

    man controls hair loss and unhappy gazing at you in the mirror 685775544 bald, baldness, loosing, prevention, hearttrob

    Male Pattern Alopecia